Preapproval Access & Gene Therapy Subgroup
The mission of the Preapproval Access and Gene Therapy Subgroup is to advance research, policy, and education regarding the ethical issues surrounding access to investigational gene-based interventions. We strive to ensure the fair and transparent treatment of all patients seeking access to gene therapies.
Rafael Escandon, PhD, DrPH, MPH
Pat Furlong, MS, RN, BSN
Lisa Kearns, MS, MA
Andrew McFadyen, MHSc, BEd
Kenneth Moch, MBA
Tom Watson, BSc
Learn more about our team and other members of NYU Langone’s Division of Medical Ethics Working Group on Compassionate Use and Preapproval Access.
For questions about the Preapproval Access and Gene Therapy subgroup, please contact John Massarelli, program coordinator, at firstname.lastname@example.org.